The authors wish to make the following correction to this paper [1].
In the original article, one author Francesca Bandinelli was missing. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Author Contributions
M.B. designed the study, collected the data, and wrote the manuscript; A.D. performed the statistical analysis; F.B. wrote the manuscript, designed methodology and performed formal analysis; F.L.G. collected the data; E.R., V.G., M.I. and M.M. performed the laboratory evaluations; M.M., A.D., M.I., E.R., A.A. and M.B. critically revised the manuscript. All authors have read and agreed to the published version of the manuscript.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Benucci M., Damiani A., Bandinelli F., Russo E., Li Gobbi F., Grossi V., Amedei A., Infantino M., Manfredi M. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022;12:1174. doi: 10.3390/jpm12071174. [DOI] [PMC free article] [PubMed] [Google Scholar]